Kaplan's posterThis was news to me, so maybe to other investors as well. It seems far more important to Promis that it would be to most of our competition, and so deserving of more promotional attention.
"Small misfolded regions (conformational epitopes) exposed on misfolded toxic A-syn, tau and Ab are sufficient to replicate the seeding activity of the full-length protein suggesting that they directly contribute to prion-like pathogenicity "